| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61dea9d55bf372a3e661e9b1954f021d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26cb4433b78031ff77fb3e072e5d4038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_702c444e7dc9d13be891db6248626257 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f730f02e73e2bdb13c68e7fddbc4e0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f8963af47bf0b92467365daa7c1f1fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a04fab9c4e31d70f1c80ba1e29285bb3 |
| publicationDate |
2004-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004035031-A2 |
| titleOfInvention |
Treatment of uveal melanoma |
| abstract |
The present invention pertains to the use of the Compound (I) of the following formula or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of uveal melanoma. |
| priorityDate |
2002-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |